Contact
Please use this form to send email to PR contact of this press release:
Cara Therapeutics Announces Summary Data From Phase 1 Trial of Oral CR845 in Hemodialysis Patients with Chronic Kidney Disease
TO:
Please use this form to send email to PR contact of this press release:
Cara Therapeutics Announces Summary Data From Phase 1 Trial of Oral CR845 in Hemodialysis Patients with Chronic Kidney Disease
TO: